Iovance Shares Jump 12% in Extended Trading
Iovance Biotherapeutics shares rose 12% in extended trading Wednesday as an upcoming lung-cancer data presentation fueled optimism about its cell therapy beyond melanoma.
Shares of Iovance Biotherapeutics (IOVA) jumped 12% in extended trading on Wednesday as an upcoming lung-cancer data presentation fueled optimism about its cell therapy’s potential beyond melanoma.IOVA stock rose nearly 2% Wednesday, bringing its weekly gain to 5% and putting it on track for a seco…